These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34022456)

  • 21. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
    J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
    Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction.
    Lee SK; Park KK; Park JH; Lim SS; Chung WY
    Phytother Res; 2013 Dec; 27(12):1776-83. PubMed ID: 23401151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
    Hussein O; Tiedemann K; Komarova SV
    Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.
    Biswas S; Nyman JS; Alvarez J; Chakrabarti A; Ayres A; Sterling J; Edwards J; Rana T; Johnson R; Perrien DS; Lonning S; Shyr Y; Matrisian LM; Mundy GR
    PLoS One; 2011; 6(11):e27090. PubMed ID: 22096521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
    Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
    J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line.
    Shimamura T; Amizuka N; Li M; Freitas PH; White JH; Henderson JE; Shingaki S; Nakajima T; Ozawa H
    Biomed Res; 2005 Aug; 26(4):159-72. PubMed ID: 16152732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The osteoblast in regulation of tumor cell dormancy and bone metastasis.
    Zarrer J; Taipaleenmäki H
    J Bone Oncol; 2024 Apr; 45():100597. PubMed ID: 38550395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.
    Jiang P; Gao W; Ma T; Wang R; Piao Y; Dong X; Wang P; Zhang X; Liu Y; Su W; Xiang R; Zhang J; Li N
    Theranostics; 2019; 9(10):2950-2966. PubMed ID: 31244935
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
    Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
    FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8
    Han YK; Jin Y; Miao YB; Shi T; Lin XP
    Inflammation; 2018 Oct; 41(5):1791-1803. PubMed ID: 29951876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary tumor-induced immunity suppresses bone metastases of breast cancer in syngeneic immunocompetent mouse models.
    Hiraga T; Nishida D; Horibe K
    Bone; 2024 Jan; 178():116944. PubMed ID: 37863157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma.
    Bhatia P; Sanders MM; Hansen MF
    Clin Cancer Res; 2005 Jan; 11(1):162-5. PubMed ID: 15671541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Educated' Osteoblasts Reduce Osteoclastogenesis in a Bone-Tumor Mimetic Microenvironment.
    Kolb AD; Dai J; Keller ET; Bussard KM
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
    Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
    Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.